CorMedix, Inc. (CRMD)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about CorMedix, Inc. (CRMD)
Go deeper and ask any question about CRMD
Company Performance
Current Price
as of Sep 13, 2024$6.95
P/E Ratio
N/A
Market Cap
$388.23M
Description
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
Metrics
Overview
- HQBerkeley Heights, NJ
- SectorHealth Technology
- IndustryBiotechnology
- TickerCRMD
- Price$6.95+1.31%
Trading Information
- Market Cap$388.23M
- Float98.19%
- Average Daily Volume (1m)909,531
- Average Daily Volume (3m)674,568
- EPS-$0.93
Company
- Revenue$0.81M
- Rev Growth (1yr)N/A
- Net Income-$14.15M
- Gross Margin36.75%
- EBITDA Margin-1,884.03%
- EBITDA-$15.19M
- EV$204.48M
- EV/Revenue253.66
- P/EN/A
- P/S496.78
Documents
SEC Filings
Factset Street Account